Mon panier

LRRC15

LRRC15 Informations sur la molécule

Nom anglaisLeucine-rich repeat-containing protein 15Nombre de médicaments commercialisés0
Nombre de médicaments cliniques0Alias de la cibleLRRC15,Leucine-rich repeat-containing protein 15,hLib,Leucine Rich Repeat Containing 15,Leucine-Rich Repeat Protein Induced By Beta-Amyloid Homolog,LIB,Leucine-Rich Repeat Protein Induced By Beta Amyloid
Phase de R&D la plus avancéePreclinical
Nom anglaisLeucine-rich repeat-containing protein 15
Alias de la cibleLRRC15,Leucine-rich repeat-containing protein 15,hLib,Leucine Rich Repeat Containing 15,Leucine-Rich Repeat Protein Induced By Beta-Amyloid Homolog,LIB,Leucine-Rich Repeat Protein Induced By Beta Amyloid
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques0
Phase de R&D la plus avancéePreclinical

LRRC15 Liste de produits

  • Attribut

    Protein (15)Cell (1)Beads (1)

  • Bibliothèque de produits

    En ligne (17)

  • Espèces

    Human (7)Mouse (4)Cynomolgus / Rhesus macaque (4)Rat (1)Canine (1)

  • Étiquette

    His Tag (5)His Tag & Avi Tag (4)Fc Tag (3)Fc Tag & Avi Tag (3)- (2)

  • Marqueur

    Unconjugated (8)Biotin-labeled (7)- (2)

LRRC15Contexte de la molécule

LRRC15 (Leucine-rich repeat-containing protein 15) is also known as LIB and hLib. LRRC15 is highly expressed in a variety of solid tumors. LRRC15 was expressed on stromal fibroblasts in many solid tumors (e.g., breast, head and neck, lung, pancreatic) as well as directly on a subset of cancer cells of mesenchymal origin (e.g., sarcoma, melanoma, glioblastoma). LRRC15 expression was induced by TGFβ on activated fibroblasts (αSMA+) and on mesenchymal stem cells. These collective findings suggested LRRC15 as a novel CAF and mesenchymal marker with utility as a therapeutic target for the treatment of cancers with LRRC15-positive stromal desmoplasia or cancers of mesenchymal origin. ABBV-085 is a monomethyl auristatin E (MMAE)-containing antibody–drug conjugate (ADC) directed against LRRC15, and it demonstrated robust preclinical efficacy against LRRC15 stromal-positive/cancer-negative, and LRRC15 cancer-positive models as a monotherapy, or in combination with standard-of-care therapies.

LRRC15Alias de la molécule

Leucine-rich repeat-containing protein 15,LRRC15,LIB,hLib
  • Informations sur la molécule
  • Liste de produits